Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) For research use only.
Not for use in humans.

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)

Synonyms: PDL192; ABT-361

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)

Purity & Quality Control

Batch: A269701 Purity: 99% Protein concentration: 4.52mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.

Product Details

CAS No. 1062149-33-0
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) | Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) supplier | purchase Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) | Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) cost | Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) manufacturer | order Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) | Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) distributor